drugset / Trial / NCT01563042

A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers

NCT01563042 ↗

Phase 1 Completed 5 enrolled GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelBasic science

Summary

An exploratory First Time in Human (FTIH) study investigating the pharmacokinetics, immunogenicity, safety and tolerability of GSK2434735 administered as a single low dose in healthy male subjects

Timeline

Start
2012-02-13
Primary completion
2012-05-23
Completion
2012-05-23

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK2434735 Unknown — Intravenous

Indications